Studies by Heddleston et al. have elucidated that HIF-2α can reprogram the nonstem population of gliomas into CSCs through the upregulation of important stem cell factors, such as Oct4, Nanog, and c-Myc [80]. The gene discussed is EPAS1; the disease is glioma.